Nivolumab vs Telmisartan
Nivolumab vs Telmisartan: Overview
This comparison examines the pharmacological differences between Nivolumab and Telmisartan.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Telmisartan — 24 hours.
Chemical Properties
Molecular Formula: Telmisartan — C33H30N4O2.
Molecular Weight: Telmisartan — 514.6230 g/mol.
Type: Nivolumab — Antibody; Telmisartan — Small molecule.